Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore, Filgen Ink Distribution Deal for Japan

NEW YORK (GenomeWeb News) – Swedish bioinformatics firm Qlucore announced on Monday a deal with Filgen to distribute Qlucore's Omics Explorer software in Japan.

Financial and other terms of the deal were not disclosed.

Omics Explorer is a software program that enables analysis of data sets from gene expression, DNA methylation, and protein expression research, as well as other fields of study. The product uses dynamic principal component analysis, which projects high dimensional data to lower dimensions. The specific projections of the data are chosen to maintain variance in the projected dataset. Data is then projected and plotted on a computer screen and rotated manually or automatically.

According to Qlucore, its deal with Filgen will provide researchers in Japan with a data analysis tool that is "powerful and yet easy to use … [that] will be invaluable for unveiling important new discoveries."

"Japan currently represents the third-largest biotech market in the world after the US and the [European Union], so this is clearly a very important opportunity for us," Qlucore President Carl-Johan Ivarsson said in a statement.

Based in Nagoya, Japan, Filgen develops, manufactures, and sells science research equipment and provides analysis services to the life sciences market.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.